Smith & Nephew plc vs Toyota Motor Corp — how do they compare? Smith & Nephew plc trades at $30.45 (market cap $12.64B), while Toyota Motor Corp trades at $180.15 (market cap $212.22B). The key difference: Toyota Motor Corp is far larger — about 16.8× Smith & Nephew plc's market cap, and Toyota Motor Corp pays the higher dividend (3.51%). Which is the better fit depends on your goals.
| SNN | TM | |
|---|---|---|
Market Cap | $12.64B | $212.22B |
Sector | Health | Consumer Cyclical |
52-Week High | $38.70 | $248.29 |
52-Week Low | $28.73 | $166.50 |
Enterprise Value | $15.41B | $376.42B |
Dividend Yield | 2.57% | 3.51% |
Signals from Pluang's Aura AI — not financial advice
SNN trades at $30.21, down 1.24% today, with a bearish technical signal and mixed earnings history. Revenue grew to $5.81B in 2024 with net income of $412M, while valuation ratios like P/E of 21.25 and P/S of 2.15 suggest moderate pricing. Recent news highlights product launches in robotics and wound care, supporting growth initiatives.
Outlook is cautiously optimistic with strong cash flow and analyst buy ratings at 27%, but risks include earnings misses and rising debt. The stock offers potential from operational improvements, though investor sentiment remains divided amid competitive pressures.
Toyota Motor (TM) trades at $180.34, up 1.54% today, showing strong fundamental metrics with a P/E of 9.78 and consistent earnings beats. Technical indicators are neutral overall, with the stock near resistance at $182. Recent news highlights a $3.6 billion Texas plant expansion to shift Tacoma production from Mexico, signaling strategic US investment.
The outlook is positive given undervaluation signals and hybrid vehicle leadership, but risks include margin pressure from rising costs and competitive auto market dynamics. Analyst consensus is mixed with 37.5% buy ratings, suggesting cautious optimism amid macroeconomic uncertainties.
Trailing returns across standard periods
Latest headlines on both assets
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.
Read more on SNN →Founded in 1937, Toyota is one of the world's largest automakers with 10.38 million units sold at retail in fiscal 2022 across its light vehicle brands. Brands include Toyota, Lexus, Daihatsu, and truck maker Hino.
Read more on TM →